Gilenya FDA Approval History
FDA Approved: Yes (First approved September 21, 2010)
Brand name: Gilenya
Generic name: fingolimod
Dosage form: Capsules
Previous Name: FTY720
Company: Novartis Pharmaceuticals Corporation
Treatment for: Multiple Sclerosis
Gilenya (fingolimod) is a sphingosine 1-phosphate receptor modulator indicated for the treatment of patients with relapsing forms of multiple sclerosis.
Development timeline for Gilenya
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.